FANTOM Post Market Clinical Trial

NCT03587922 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500

Last updated 2024-06-14

No results posted yet for this study

Summary

Post Market study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold

Conditions

Interventions

DEVICE

Fantom

Treatment of den ovo coronary lesions

Sponsors & Collaborators

  • REVA Medical, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2025-05-01
Completion
2025-05-01

Countries

  • Austria
  • Germany
  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03587922 on ClinicalTrials.gov